Madeline K. M. Kwok
YOU?
Author Swipe
View article: Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy
Risk of recurrence of retinopathy of prematurity after initial intravitreal ranibizumab therapy Open
We report our experience with the use of intravitreal ranibizumab for the treatment of retinopathy of prematurity (ROP). A retrospective review was performed on 138 consecutive infants screened at a single centre over 18 months. Intravitre…